KLRB1 expression, but not PD‐1 expression, correlates with TRM exhaustion, suggesting that KLRB1 may deliver a broad inhibitory signal to CD8+ TRM in hematological malignancies. This evidence concerns the gene CD8A and hematologic disorder.